2009
HIV Incidence Rates and Risk Factors for Urban Women in Zambia: Preparing for a Microbicide Clinical Trial
Kapina M, Reid C, Roman K, Cyrus-Cameron E, Kwiecien A, Weiss S, Vermund SH. HIV Incidence Rates and Risk Factors for Urban Women in Zambia: Preparing for a Microbicide Clinical Trial. Sexually Transmitted Diseases 2009, 36: 129-133. PMID: 19174729, PMCID: PMC2889146, DOI: 10.1097/olq.0b013e318190191d.Peer-Reviewed Original ResearchConceptsHigh HIV prevalenceHIV prevalenceHIV incidenceIncidence rateHighest age-specific prevalenceHuman immunodeficiency virus (HIV) incidencePreparedness studiesBaseline HIV prevalenceRisk reduction counselingAge-specific prevalenceHIV incidence ratesMicrobicide clinical trialsWomen yearsSexual behavioral characteristicsPopulation of womenSame study proceduresGeneral population sampleHIV acquisitionReduction counselingEligible womenHIV/Infection testingRisk factorsClinical trialsPregnancy rate
2002
Protease Inhibitor Combination Therapy and Decreased Condom Use Among Gay Men
DiCLEMENTE RJ, FUNKHOUSER E, WINGOOD G, FAWAL H, HOLMBERG SD, VERMUND SH. Protease Inhibitor Combination Therapy and Decreased Condom Use Among Gay Men. Southern Medical Journal 2002, 95: 421-425. PMID: 11958240, DOI: 10.1097/00007611-200204000-00009.Peer-Reviewed Original ResearchConceptsProtease inhibitorsProtease inhibitor combination therapyActive heterosexual menHIV-infected personsHigh-risk sexual behaviorRisk reduction counselingInhibitor combination therapyAssociation of treatmentSexual behaviorUnprotected sexual behaviorHigh-risk practicesMedication useCombination therapyPotential confoundersPublic clinicsHealth statusCondom useCurrent sexual practicesMenTreatmentSexual practicesHeterosexual menInhibitorsAlabama communitiesCondomsProtease Inhibitor Combination Therapy and Decreased Condom Use Among Gay Men
DICLEMENTE R, FUNKHOUSER E, WINGOOD G, FAWAL H, HOLMBERG S, VERMUND S. Protease Inhibitor Combination Therapy and Decreased Condom Use Among Gay Men. Southern Medical Journal 2002, 95: 421-425. DOI: 10.1097/00007611-200295040-00010.Peer-Reviewed Original ResearchProtease inhibitorsProtease inhibitor combination therapyActive heterosexual menHIV-infected personsHigh-risk sexual behaviorRisk reduction counselingInhibitor combination therapyAssociation of treatmentSexual behaviorUnprotected sexual behaviorHigh-risk practicesMedication useCombination therapyPotential confoundersPublic clinicsHealth statusCondom useCurrent sexual practicesMenTreatmentSexual practicesHeterosexual menInhibitorsAlabama communitiesCondoms